Claim · claimSorter/cs-011
The 1968 Schedule I classification of LSD was a scientific judgment based on evidence of harm
Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.
The 1968 Schedule I classification of LSD was a scientific judgment based on evidence of harm
Refuted recorded as “Falsified” Storming Heaven
WHO Critical Review (2019) found no evidence supporting LSD's current scheduling level (Source not found; under review). FDA Breakthrough Therapy designation for psilocybin (2018) acknowledged classical psychedelics may have accepted medical use. Global Drug Survey 2016: LSD had lowest emergency medical treatment rate of any surveyed substance. Zero overdose deaths from LSD toxicity documented in 80 years. The scheduling was political.
Stevens (1987); WHO ECDD (2019); FDA (2018)
Links for this item
- Posts
- No post is recorded for this item yet.
- Source page
- The sources for this item on RN Collins Selected Work
- Long-form
- Stevens's Thesis: Was the 1968 Prohibition Evidence-Based?, the editorial draft this item belongs with
- Gallery
- See it in the gallery index
- Project
- About this library on RN Collins Selected Work
- Corrections
- Publication rules and the correction form
Course modules that use this claim
- The Suppression Course module
Drafts on the same book
- The Curious Molecule and the Country It Broke Editorial draft
- Ken Kesey and the Acid Tests Editorial draft
- Stanislav Grof and the Cartography of the Psyche Editorial draft
- The Hollywood Sessions Editorial draft
- October 6, 1968: The Last Day Editorial draft
- Osmond in New York: The APA Roundtable Editorial draft
- Alan Watts and the Problem of Integration Editorial draft
- The Second Wave: Why History Is Repeating and How It Might Not Editorial draft
- MDMA's FDA Rejection: A 1968 Pattern in 2024 Editorial draft
- The Bipartisan Moment: Veterans, Ibogaine, and the New Political Map Editorial draft
- State vs. Federal: The Legal Landscape After Oregon and Colorado Editorial draft
- Public vs. Private: Who Funds the Psychedelic Research Program Editorial draft
- Was It Leary's Fault? Editorial draft
- What the CIA Was Looking For Editorial draft
- Huxley's Warning: The Letter That Wasn't Heeded Editorial draft
- The Resumption: Picking Up Where 1968 Left Off Editorial draft
- The Two Worlds: Clinic and Culture Cannot Be Separated Editorial draft
- Stevens's Thesis: Was the 1968 Prohibition Evidence-Based? Editorial draft
- Passage: The Day the Research Stopped Editorial draft
- MDMA After the Rejection: What the 2024 FDA Decision Actually Means Editorial draft
Reading list for this book
- Reading list: Storming Heaven Reading list
NotebookLM packs on this book
- The CIA and the Clinic NotebookLM source pack
Bridge pieces that use this book
Science annotations on this book
- Timewave Zero: history accelerates toward a final moment of "maximum novelty" predicted for December 21, 2012. Science annotation
Then vs. Now comparisons on this book
- Psychedelic Prohibition: What the Evidence Actually Showed Then vs. Now comparison
- The Anslinger Theory: Was the Drug War Racist? Then vs. Now comparison
- The Psychedelic Research Interruption: 1968-2018 Then vs. Now comparison
- The CIA and LSD: What MK-Ultra Actually Produced Then vs. Now comparison
- Leary vs. Osmond: The Two Psychedelic Models Then vs. Now comparison
- The Veterans' Ibogaine Breakthrough: A 1968 Pattern That Didn't Repeat Then vs. Now comparison
- Stanislav Grof's Legacy: Has His Cartography Been Validated? Then vs. Now comparison
- MDMA After the FDA Rejection: A 1968 Pattern or a 2024 Delay? Then vs. Now comparison
- The Leary Legacy Reassessed: Was He Entirely Wrong? Then vs. Now comparison
- Holotropic Breathwork as Proof of Concept: Non-Drug Non-Ordinary States Then vs. Now comparison